Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach

Modern Pathology

Volumn 21, Issue 4, 2008, Pages 464-475

  Sentani, Kazuhiro ^a   Oue, Naohide ^a   Sakamoto, Naoya ^a   Arihiro, Koji ^b   Aoyagi, Kazuhiko ^c   Sasaki, Hiroki ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Gastric cancer; Hepatocellular carcinoma; Hepatoid adenocarcinoma; Microarray; PLUNC; SAGE

Indexed keywords

PALATE LUNG AND NASAL EPITHELIUM CARCINOMA ASSOCIATED PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; GASTRIC HEPATOID ADENOCARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SERIAL ANALYSIS OF GENE EXPRESSION; STOMACH CARCINOMA; UPREGULATION;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 41149166324     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3801050     Document Type: Article

References (33)

1. Ohgaki H, Matsukura N. Stomach cancer. In: Stewart BW, Kleihues P (eds). World Cancer Report. IARC Press: Lyon, 2003, pp 197.
2. Yasui W, Oue N, Kitadai Y, et al. Recent advances in molecular pathobiology of gastric carcinoma. In: Kaminishi M, Takubo K, Mafune K (eds). The Diversity of Gastric Carcinoma Pathogenesis: Diagnosis, and Therapy. Springer: Tokyo, 2005, pp 51-71.
3. Kondo T, Oue N, Mitani Y, et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 2005;24:157-164.
4. Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006;66:10439-10448.
5. Yasui W, Oue N, Ito R, et al. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004;95:385-392.
6. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-1680.
7. Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression. Science 1995;270:484-487.
8. Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004;64:2397-2405.
9. Aung PP, Oue N, Mitani Y, et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2006;25:2546-2557.
10. Ishii M, Hashimoto S, Tsutsumi S, et al. Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics 2000;68:136-143.
11. Oue N, Aung PP, Mitani Y, et al. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 2005;69(Suppl 1):17-22.
12. Weston WM, LeClair EE, Trzyna W, et al. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J Biol Chem 1999;274:13698-13703.
13. Bingle CD, Bingle L. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta 2000;1493:363-367.
14. Iwao K, Watanabe T, Fujiwara Y, et al. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Int J Cancer 2001;91:433-437.
15. Bingle L, Cross SS, High AS, et al. SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype. J Pathol 2005;205:491-497.
16. Sobin LH, Wittekind CH, (eds). TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss Inc: New York, 2002, pp 65-68.
17. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-315.
18. Nishigaki M, Aoyagi K, Danjoh I, et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res 2005;65:2115-2124.
19. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
20. Kondo T, Oue N, Yoshida K, et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004;64:523-529.
21. Yasui W, Ayhan A, Kitadai Y, et al. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993;53:36-41.
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
23. El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002;62:6823-6826.
24. Inoue H, Mori M, Honda M, et al. The expression of tumor-rejection antigen 'MAGE' genes in human gastric carcinoma. Gastroenterology 1995;109:1522-1525.
25. David L, Nesland JM, Holm R, et al. Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer 1994;73:518-527.
26. Ueki T, Koji T, Tamiya S, et al. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. J Pathol 1995;177:353-361.
27. Terracciano LM, Glatz K, Mhawech P, et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol 2003;27:1302-1312.
28. Chang YC, Nagasue N, Abe S, et al. Alpha fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 1991;32:542-545.
29. Ishikura H, Kishimoto T, Andachi H, et al. Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases. Histopathology 1997;31:47-54.
30. Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 1986;58:119-126.
31. Hishinuma M, Ohashi KI, Yamauchi N, et al. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein- producing gastric carcinoma. Histopathology 2006;49:479-486.
32. Supriatna Y, Kishimoto T, Uno T, et al. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA. Pathology 2005;37:211-215.
33. Kishimoto T, Nagai Y, Kato K, et al. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis. Med Electron Microsc 2000;33:57-63.